| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1048125449 |
| P356 | DOI | 10.1038/NRNEUROL.2016.149 |
| P698 | PubMed publication ID | 27786246 |
| P50 | author | Martha Quezado | Q110348734 |
| P2093 | author name string | Avindra Nath | |
| Daniel Reich | |||
| Bryan Smith | |||
| Lauren N Bowen | |||
| P2860 | cites work | Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study | Q21144623 |
| Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast | Q24620256 | ||
| Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome | Q24630287 | ||
| Clinically Available Medicines Demonstrating Anti-Toxoplasma Activity | Q26782581 | ||
| American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America | Q29391534 | ||
| Rapid molecular detection of tuberculosis and rifampin resistance | Q29617127 | ||
| HIV and Tuberculosis: a Deadly Human Syndemic | Q30052157 | ||
| Toxoplasmosis | Q30080013 | ||
| PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section | Q30613846 | ||
| Progressive multifocal leukoencephalopathy: value of diffusion-weighted and contrast-enhanced magnetic resonance imaging for diagnosis and treatment control | Q31050655 | ||
| Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era. | Q33328474 | ||
| PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids | Q33398308 | ||
| Role of interferon gamma release assay in active TB diagnosis among HIV infected individuals | Q33455753 | ||
| Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases | Q33540873 | ||
| Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study | Q48828618 | ||
| Clinical features, outcome and survival from cerebral toxoplasmosis in Edinburgh AIDS patients | Q48971633 | ||
| Referral patterns of uveitis in a tertiary eye care center. | Q51034605 | ||
| Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients. | Q53913334 | ||
| Technology for automated, rapid, and quantitative PCR or reverse transcription-PCR clinical testing. | Q54677443 | ||
| Clinical patterns of uveitis in two ophthalmology centres in Bogota, Colombia | Q56452673 | ||
| Survival after neuroAIDS: Association with antiretroviral CNS Penetration-Effectiveness score | Q56762687 | ||
| Prevalence, Associated Factors, and Prognostic Determinants of AIDS‐Related Toxoplasmic Encephalitis in the Era of Advanced Highly Active Antiretroviral Therapy | Q58798156 | ||
| Diffuse "encephalitic" cerebral toxoplasmosis in AIDS. Report of four cases | Q69681126 | ||
| [Aspecific chorioretinitis as initial manifestation of HIV infection and diffuse Toxoplasma encephalitis] | Q71199973 | ||
| The natural history of progressive multifocal leukoencephalopathy in patients with AIDS. Canadian PML Study Group | Q71910931 | ||
| Development of cytomegalovirus (CMV) disease may be predicted in HIV-infected patients by CMV polymerase chain reaction and the antigenemia test | Q73331357 | ||
| A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group | Q74579193 | ||
| Movement disorders in 28 HIV-infected patients | Q74817805 | ||
| Diagnostic accuracy of HIV-associated central nervous system toxoplasmosis | Q77750726 | ||
| Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection | Q33597147 | ||
| Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of Amer | Q33650105 | ||
| Trends in AIDS-defining opportunistic illnesses incidence over 25 years in Rio de Janeiro, Brazil | Q33717183 | ||
| Toxoplasma gondii seroprevalence in the United States 2009-2010 and comparison with the past two decades | Q33719625 | ||
| Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa | Q33871884 | ||
| Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions | Q33980117 | ||
| Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults | Q33982474 | ||
| Pretreatment intracerebral and peripheral blood immune responses in Vietnamese adults with tuberculous meningitis: diagnostic value and relationship to disease severity and outcome | Q33992984 | ||
| Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis | Q34024416 | ||
| Activated microglia contribute to neuronal apoptosis in Toxoplasmic encephalitis | Q34084926 | ||
| Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside | Q34087794 | ||
| Ocular toxoplasmosis in AIDS patients | Q34164395 | ||
| JC virus granule cell neuronopathy: A novel clinical syndrome distinct from progressive multifocal leukoencephalopathy | Q34405800 | ||
| Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease | Q34538727 | ||
| Lessons learned from fatal progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with natalizumab | Q34556743 | ||
| Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy | Q34590916 | ||
| Spectrums of opportunistic infections and malignancies in HIV-infected patients in tertiary care hospital, China | Q35034520 | ||
| Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis | Q35121804 | ||
| Prospective Analysis of 55 Cases of Tuberculosis Meningitis (TBM) in North India | Q35139585 | ||
| A 10-year retrospective comparison of two target sequences, REP-529 and B1, for Toxoplasma gondii detection by quantitative PCR. | Q35193272 | ||
| The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis | Q35635476 | ||
| Epidemiological characterization and prognostic factors in patients with confirmed cerebral cryptococcosis in central Taiwan | Q35806654 | ||
| Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010 | Q35826942 | ||
| Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis | Q35919786 | ||
| The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme. | Q36012849 | ||
| Paradoxical reaction in tuberculous meningitis: presentation, predictors and impact on prognosis | Q36058313 | ||
| Human Immune Response Varies by the Degree of Relative Cryptococcal Antigen Shedding | Q36488971 | ||
| Natural History and Factors Associated with Early and Delayed Mortality in HIV-Infected Patients Treated of Tuberculosis under Directly Observed Treatment Short-Course Strategy: A Prospective Cohort Study in India | Q36505791 | ||
| Comparison of conventional bacteriology with nucleic acid amplification (amplified mycobacterium direct test) for diagnosis of tuberculous meningitis before and after inception of antituberculosis chemotherapy | Q36600379 | ||
| Cryptococcal meningoencephalitis relapse after an eight-year delay: an interplay of infection and immune reconstitution | Q36653764 | ||
| Tuberculous meningitis: presentation, diagnosis and outcome in hiv-infected patients at the douala general hospital, cameroon: a cross sectional study | Q36940677 | ||
| Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study | Q37052988 | ||
| A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes | Q37135539 | ||
| Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis | Q37401607 | ||
| Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study | Q37434587 | ||
| Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes | Q37579943 | ||
| Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases | Q37714089 | ||
| Tuberculous meningitis: a uniform case definition for use in clinical research | Q37786102 | ||
| HIV-associated tuberculous meningitis--diagnostic and therapeutic challenges. | Q37794462 | ||
| Current issues in the diagnosis and management of tuberculosis and HIV coinfection in the United States | Q37812220 | ||
| Neurologic cytomegalovirus complications in patients with AIDS: retrospective review of 13 cases and review of the literature | Q37827727 | ||
| HIV-associated opportunistic infections of the CNS. | Q38019772 | ||
| Treatment optimization in patients co-infected with HIV and Mycobacterium tuberculosis infections: focus on drug-drug interactions with rifamycins | Q38207924 | ||
| HIV-associated central nervous system diseases in the recent combination antiretroviral therapy era. | Q38441425 | ||
| Spectrum of imaging appearances of intracranial cryptococcal infection in HIV/AIDS patients in the anti-retroviral therapy era. | Q38632430 | ||
| Opportunistic Neurologic Infections in Patients with Acquired Immunodeficiency Syndrome (AIDS). | Q38690896 | ||
| Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda | Q38877605 | ||
| Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults | Q38884510 | ||
| Shunting in cryptococcal meningitis | Q39181409 | ||
| Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial | Q39248895 | ||
| Clinical spectrum in 107 cases of toxoplasmic lymphadenopathy | Q39694738 | ||
| Development of a multiplex real-time PCR for the simultaneous detection of herpes simplex and varicella zoster viruses in cerebrospinal fluid and lesion swab specimens | Q40164291 | ||
| CNS cryptococcoma in an HIV-positive patient | Q40551411 | ||
| Multidrug-resistant tuberculous meningitis in patients with AIDS | Q40559743 | ||
| Progressive multifocal leukoencephalopathy masquerading as cerebellar infarction | Q40724070 | ||
| Movement disorders with cerebral toxoplasmosis and AIDS. | Q40868671 | ||
| Roth Spots in Ocular Toxoplasmosis | Q40949828 | ||
| Voriconazole: a novel treatment option for cryptococcal meningitis. | Q41145601 | ||
| Toxoplasma chorioretinitis diagnosed by histopathology in a patient with AIDS. | Q41521987 | ||
| Isolated cortical blindness without simultaneous neurological involvement in progressive multifocal leukoencephalopathy in a patient with human immune deficiency virus infection. | Q41571776 | ||
| Cryptoccocal meningitis in Yaoundé (Cameroon) HIV infected patients: Diagnosis, frequency and Cryptococcus neoformans isolates susceptibility study to fluconazole | Q41622633 | ||
| Neurological, visual, and MRI brain scan findings in 87 South African patients with HIV-associated cryptococcal meningoencephalitis | Q41637386 | ||
| Combination antifungal therapy for cryptococcal meningitis | Q41924502 | ||
| Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current era. | Q42251011 | ||
| Diagnosis of cerebral toxoplasmosis in AIDS patients in Brazil: importance of molecular and immunological methods using peripheral blood samples | Q42561323 | ||
| A Novel Case of Solitary Cerebral Toxoplasmosis Mimicking Glioblastoma as the First Presentation of HIV. | Q42906594 | ||
| IgG4 specific to Toxoplasma gondii excretory/secretory antigens in serum and/or cerebrospinal fluid support the cerebral toxoplasmosis diagnosis in HIV-infected patients | Q43651070 | ||
| A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis. | Q43955899 | ||
| A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS. | Q44129718 | ||
| Multidrug-resistant tuberculous meningitis in KwaZulu-Natal, South Africa. | Q44785824 | ||
| Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection | Q45056526 | ||
| Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression. | Q45175638 | ||
| Progressive multifocal leukoencephalopathy presenting with an isolated focal movement disorder | Q45228797 | ||
| Anti-JC virus antibodies: implications for PML risk stratification | Q45373492 | ||
| Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy | Q45386676 | ||
| Progressive multifocal leukoencephalopathy: a confused woman, an ambitious virus and an unusual MRI. | Q45732343 | ||
| Ocular toxoplasmosis in human immunodeficiency virus-infected patients. | Q45878249 | ||
| Intravitreal triamcinolone acetonide for the treatment of immune recovery uveitis macular edema | Q46405191 | ||
| Early biopsy versus empiric treatment with delayed biopsy of non-responders in suspected HIV-associated cerebral toxoplasmosis: a decision analysis | Q46543459 | ||
| Progressive multifocal leukoencephalopathy in a patient with acquired immunodeficiency syndrome (AIDS) manifesting Gerstmann's syndrome | Q48199300 | ||
| The host-parasite relationship of Toxoplasma gondii in the brains of chronically infected mice | Q48251099 | ||
| Outbreak of central-nervous-system toxoplasmosis in western Europe and North America | Q48662823 | ||
| Toxoplasma gondii: determination of the onset of chronic infection in mice and the in vitro reactivation of brain cysts. | Q48821154 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 662-674 | |
| P577 | publication date | 2016-10-01 | |
| P1433 | published in | Nature Reviews Neurology | Q2079285 |
| P1476 | title | HIV-associated opportunistic CNS infections: pathophysiology, diagnosis and treatment | |
| P478 | volume | 12 |
| Q49385585 | Cryptococcal Meningoencephalitis Complicated by Subdural Empyema in an 8-Year-Old Girl With Neonatal-Onset Multisystem Inflammatory Disease Syndrome: A Rare Sequela |
| Q47559355 | Despite Gains, the War on HIV Is Far From Over: With No Cure in Sight, Experts Urge Early Diagnosis and Prompt Treatment With Better Adherence |
| Q48190631 | Direct genetic characterization of Toxoplasma gondii from clinical samples from Denmark: not only genotypes II and III. |
| Q89786056 | Fulminant central nervous system varicella-zoster virus infection unexpectedly diagnosed by metagenomic next-generation sequencing in an HIV-infected patient: a case report |
| Q92720553 | HIV-Related Cerebral Toxoplasmosis Revisited: Current Concepts and Controversies of an Old Disease |
| Q49905059 | Image Gallery: Cutaneous presentation of disseminated cryptococcosis in a patient with undiagnosed HIV infection |
| Q90009354 | Isolation, identification, and phylogenetic analysis of potentially pathogenic free-living amoebae isolated from nasal and oral mucosa of HIV/AIDS patients in Iran |
| Q89738686 | Merkel cell carcinoma |
| Q40046580 | Merkel cell polyomavirus and Merkel cell carcinoma. |
| Q60932879 | Metagenomic next-generation sequencing as a diagnostic tool for toxoplasmic encephalitis |
| Q92251781 | Mortality by cryptococcosis in Brazil from 2000 to 2012: A descriptive epidemiological study |
| Q93097902 | Mortality in adult patients with culture-positive and culture-negative meningitis in the Botswana national meningitis survey: a prevalent cohort study |
| Q42350676 | Noninvasive intracranial pressure monitoring for HIV-associated cryptococcal meningitis |
| Q40074359 | Opportunistic Invasive Mycoses in AIDS: Cryptococcosis, Histoplasmosis, Coccidiodomycosis, and Talaromycosis |
| Q91867877 | Progressive Multifocal Leukoencephalopathy Diagnosed by Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid in an HIV Patient |
| Q39388323 | Protective and Pathological Immunity during Central Nervous System Infections |
| Q61807034 | Resistance and Tolerance to Cryptococcal Infection: An Intricate Balance That Controls the Development of Disease |
| Q39074774 | Roles of regulatory T cells and IL-10 in virus-induced demyelination |
| Q92717698 | Serological and molecular rapid diagnostic tests for Toxoplasma infection in humans and animals |
| Q64959034 | The neuropathology of the adult cerebellum. |
Search more.